COVID-19-related outcomes in immunocompromised patients: A nationwide study in Korea.

ABSTRACT:

Background

Given the rapid increased in confirmed coronavirus disease 2019 (COVID-19) and related mortality, it is important to identify vulnerable patients. Immunocompromised status is considered a risk factor for developing severe COVID-19. We aimed to determine whether immunocompromised patients with COVID-19 have an increased risk of mortality.

Method

The groups' baseline characteristics were balanced using a propensity score-based inverse probability of treatment weighting approach. Odds ratios (ORs) and their 95% confidence intervals (CIs) were calculated for the risks of in-hospital mortality and other outcomes according to immunocompromised status using a multivariable logistic regression model. We identified immunocompromised status based on a diagnosis of malignanc

SUBMITTER: Baek MS 

PROVIDER: S-EPMC8486114 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature